Search CORE

2 research outputs found

Safety and efficacy of ravidasvir plus sofosbuvir 12 weeks in non-cirrhotic and 24 weeks in cirrhotic patients with hepatitis C virus genotypes 1, 2, 3 and 6 : the STORM-C-1 phase II/III trial

Author: Andrieux-Meyer I.
Asimah N.
Avihingsanon A.
Brenner J.
Chan W. K.
Cressey T. R.
Da Silva N.
Goh K. L.
Hassan M. R. A.
Kamarulzaman A.
Khemnark S.
Kumar S.
Lallemant Marc
Murad S.
Omar H.
Omar S. F. S.
Pecoul B.
Piedagnel J. M.
Said Hrhm
Salvadori Nicolas
Simon F.
Siva S.
Tan S. S.
Tee H. P.
Thanprasertsuk S.
Thetket K.
Thongsawat S.
Publication venue
Publication date: 01/01/2018
Field of study

Horizon / Pleins textes

Safety and efficacy of ravidasvir plus sofosbuvir 12 weeks in noncirrhotic and 24 weeks in cirrhotic patients with hepatitis C virus genotypes 1, 2, 3 and 6: The STORM-C-1 phase II/III trial

Author: A. Avihingsanon
A. Kamarulzaman
B. Pecoul
F. Simon
H. Omar
H.P. Tee
H.R.H.M. Said
I. Andrieux-Meyer
J. Brenner
J.-M. Piedagne
K. Thetket
K.L. Goh
M. Lallemant
M.R.A. Hassan
N. Asimah
N. Da Silva
N. Salvadori
S. Khemnark
S. Kumar
S. Murad
S. Siva
S. Thanprasertsuk
S. Thongsawat
S.-S. Tan
S.F.S. Omar
T.R. Cressey
W.-K. Chan
Publication venue: 'Elsevier BV'
Publication date
Field of study

core

core